According to this study, over the next five years the Prostacyclin market will register a 5.1% CAGR in terms of revenue, the global market size will reach $ 2316.6 million by 2025, from $ 1899.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostacyclin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostacyclin market by type, application, key manufacturers and key regions and countries.

This study considers the Prostacyclin value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Epoprostenol Sodium

Treprostinil

Iloprost

Beraprost Sodium

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

For Injection

For Oral

For Inhalation

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

United Therapeutics

Actelion (J & J)

Teva

Toray

GSK

Tide Pharma

Bayer AG

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Prostacyclin consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Prostacyclin market by identifying its various subsegments.

Focuses on the key global Prostacyclin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Prostacyclin with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Prostacyclin submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prostacyclin Consumption 2015-2025

2.1.2 Prostacyclin Consumption CAGR by Region

2.2 Prostacyclin Segment by Type

2.2.1 Epoprostenol Sodium

2.2.2 Treprostinil

2.2.3 Iloprost

2.2.4 Beraprost Sodium

2.3 Prostacyclin Consumption by Type

2.3.1 Global Prostacyclin Consumption Market Share by Type (2015-2020)

2.3.2 Global Prostacyclin Revenue and Market Share by Type (2015-2020)

2.3.3 Global Prostacyclin Sale Price by Type (2015-2020)

2.4 Prostacyclin Segment by Application

2.4.1 For Injection

2.4.2 For Oral

2.4.3 For Inhalation

2.5 Prostacyclin Consumption by Application

2.5.1 Global Prostacyclin Consumption Market Share by Type (2015-2020)

2.5.2 Global Prostacyclin Value and Market Share by Type (2015-2020)

2.5.3 Global Prostacyclin Sale Price by Type (2015-2020)

3 Global Prostacyclin by Company

3.1 Global Prostacyclin Sales Market Share by Company

3.1.1 Global Prostacyclin Sales by Company (2018-2020)

3.1.2 Global Prostacyclin Sales Market Share by Company (2018-2020)

3.2 Global Prostacyclin Revenue Market Share by Company

3.2.1 Global Prostacyclin Revenue by Company (2018-2020)

3.2.2 Global Prostacyclin Revenue Market Share by Company (2018-2020)

3.3 Global Prostacyclin Sale Price by Company

3.4 Global Prostacyclin Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Prostacyclin Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Prostacyclin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Prostacyclin by Regions

4.1 Prostacyclin by Regions

4.2 Americas Prostacyclin Consumption Growth

4.3 APAC Prostacyclin Consumption Growth

4.4 Europe Prostacyclin Consumption Growth

4.5 Middle East & Africa Prostacyclin Consumption Growth

5 Americas

5.1 Americas Prostacyclin Consumption by Countries

5.1.1 Americas Prostacyclin Consumption by Countries (2015-2020)

5.1.2 Americas Prostacyclin Value by Countries (2015-2020)

5.2 Americas Prostacyclin Consumption by Type

5.3 Americas Prostacyclin Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Prostacyclin Consumption by Regions

6.1.1 APAC Prostacyclin Consumption by Regions (2015-2020)

6.1.2 APAC Prostacyclin Value by Regions (2015-2020)

6.2 APAC Prostacyclin Consumption by Type

6.3 APAC Prostacyclin Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Prostacyclin by Countries

7.1.1 Europe Prostacyclin Consumption by Countries (2015-2020)

7.1.2 Europe Prostacyclin Value by Countries (2015-2020)

7.2 Europe Prostacyclin Consumption by Type

7.3 Europe Prostacyclin Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Prostacyclin by Countries

8.1.1 Middle East & Africa Prostacyclin Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Prostacyclin Value by Countries (2015-2020)

8.2 Middle East & Africa Prostacyclin Consumption by Type

8.3 Middle East & Africa Prostacyclin Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Prostacyclin Distributors

10.3 Prostacyclin Customer

11 Global Prostacyclin Market Forecast

11.1 Global Prostacyclin Consumption Forecast (2021-2025)

11.2 Global Prostacyclin Forecast by Regions

11.2.1 Global Prostacyclin Forecast by Regions (2021-2025)

11.2.2 Global Prostacyclin Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Prostacyclin Forecast by Type

11.8 Global Prostacyclin Forecast by Application

12 Key Players Analysis

12.1 United Therapeutics

12.1.1 Company Information

12.1.2 Prostacyclin Product Offered

12.1.3 United Therapeutics Prostacyclin Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 United Therapeutics Latest Developments

12.2 Actelion (J & J)

12.2.1 Company Information

12.2.2 Prostacyclin Product Offered

12.2.3 Actelion (J & J) Prostacyclin Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Actelion (J & J) Latest Developments

12.3 Teva

12.3.1 Company Information

12.3.2 Prostacyclin Product Offered

12.3.3 Teva Prostacyclin Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Teva Latest Developments

12.4 Toray

12.4.1 Company Information

12.4.2 Prostacyclin Product Offered

12.4.3 Toray Prostacyclin Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Toray Latest Developments

12.5 GSK

12.5.1 Company Information

12.5.2 Prostacyclin Product Offered

12.5.3 GSK Prostacyclin Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 GSK Latest Developments

12.6 Tide Pharma

12.6.1 Company Information

12.6.2 Prostacyclin Product Offered

12.6.3 Tide Pharma Prostacyclin Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Tide Pharma Latest Developments

12.7 Bayer AG

12.7.1 Company Information

12.7.2 Prostacyclin Product Offered

12.7.3 Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Bayer AG Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Prostacyclin Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Epopro